Zhumin Cao | Clinical Trials | Best Researcher Award

Zhumin Cao | Clinical Trials | Best Researcher Award

Prof. Zhumin Cao, The Seventh People’s Hospital of Chongqing, China

Prof. Zhumin Cao is a dedicated clinician and researcher in vascular diseases πŸ«€, with extensive experience in both basic and clinical research. He has served as a Visiting Scholar at Ajoy University Hospital πŸ‡°πŸ‡· and Carl Gustav Carus University Hospital πŸ‡©πŸ‡ͺ. Prof. Cao has led five funded research projects and published 20+ papers, including 10+ SCI articles with a cumulative impact factor of 40+ πŸ“Š. His current focus is on early intracavitary treatment of pulmonary embolism, pioneering innovations in patient care. He is also a reviewer for Angiology and Frontiers πŸ“.

Publication Profile

Scopus

Education

Prof. Zhumin Cao has dedicated his career to clinical and basic research in vascular diseases πŸ«€. He has served as a Visiting Scholar at Ajoy University Hospital in South Korea πŸ‡°πŸ‡· and University Hospital Carl Gustav Carus in Germany πŸ‡©πŸ‡ͺ. His leadership includes two provincial and three departmental-level projects πŸ“Š. He actively contributes to the scientific community as a peer reviewer for Angiology and Frontiers πŸ“. Prof. Cao has authored over 20 research papers, including 10+ SCI-indexed publications, with a combined impact factor of 40+, and a single article IF reaching 11.4 🌟.

Areas of Research

Prof. Zhumin Cao specializes in the field of vascular diseases πŸ«€, with a primary research focus on the early treatment of pulmonary embolism πŸ«β€”a life-threatening and time-sensitive condition that poses significant challenges in clinical practice ⏱️. His work aims to improve therapeutic strategies and patient outcomes through intracavitary interventions and innovative approaches in vascular care πŸ’‰. By bridging clinical application and basic research, Prof. Cao’s studies contribute meaningfully to the development of evidence-based practices in cardiovascular medicine 🌍. His dedication supports advancements in critical care and interventional procedures that save lives every day ❀️.

Research Focus

Prof. Zhumin Cao’s research delves into the role of Interleukin-6 (IL-6) in reshaping the tumor microenvironment 🧫, a key factor in cancer progression and resistance to therapy. His work explores how IL-6-driven changes affect immune cell behavior and tumor dynamics 🧬. By understanding this cytokine’s influence, he aims to enhance the effectiveness of cancer immunotherapy πŸ’‰, offering new avenues for targeted treatments. This research bridges oncology and immunology, contributing to breakthroughs in precision medicine 🧠. Prof. Cao’s findings could lead to improved outcomes for patients battling aggressive cancers through innovative immunomodulatory strategies 🎯.

Publication Top Notes

Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy

Annik Caliezi | Clinical Trials | Best Researcher Award

Annik Caliezi | Clinical Trials | Best Researcher Award

Ms. Annik Caliezi, Dermatologie Inselspital, Switzerland

Annik Caliezi is a dedicated medical student in her 10th semester of the Master of Medicine program at the University of Bern. She holds a Bachelor’s in Medicine and a bilingual Matura in Economics and Law. With hands-on experience as a nursing assistant at Careanesth and an OR assistant in hand surgery, Annik has also contributed to histology and anatomy education. Her research focuses on Hidradenitis Suppurativa and its impact on sexual quality of life, with publications in MDPI. Fluent in German, English, and French, she holds multiple life support certifications. πŸ”¬πŸ“š

Publication Profile

orcid

Education

Ms. Annik Caliezi πŸŽ“ is currently in the 10th semester of her Master of Medicine at the University of Bern πŸ₯, where she has been pursuing her studies since 2023. Prior to this, she completed her Bachelor of Medicine (2020–2023) at the same institution, building a strong foundation in medical sciences πŸ”¬. Her academic journey began with a bilingual Matura in Economics and Law πŸ“šβš–οΈ at Gymnasium Kirchenfeld Bern (2015–2019), where she developed analytical and interdisciplinary skills. With a passion for medicine and a commitment to excellence, she continues to advance in her medical education and training. πŸš€

Experience

Ms. Annik Caliezi πŸ₯ has gained diverse work experience in healthcare and beyond. Since May 2024, she has been working as a nursing assistant at Careanesth 🩺, and since May 2023, she has served as an OR Assistant in Hand Surgery at Permanence Hospital Hirslanden Bern βœ‹πŸ½πŸ”¬. Previously, she assisted in histology and anatomy courses at the University of Bern (10/2022–05/2023) πŸ§«πŸ“š. Since December 2021, she has been interning at Bahnhofpraxis Wichtrach πŸš‘. Her earlier experiences include a geriatric rehabilitation internship (2021) πŸ‘΅πŸΌ, a role as a waitress (2019–2020) β˜•, and an activity therapy internship (2018) 🏑.

Awards

Ms. Annik Caliezi πŸ₯ has earned several valuable certifications in healthcare and language proficiency. In 2024, she became an Immediate Life Support (ILS) Provider through the European Resuscitation Council πŸš‘. She also completed the French course “FranΓ§ais pour futur mΓ©decin” (2023) πŸ©ΊπŸ‡«πŸ‡·, enhancing her medical communication skills. Additionally, she holds Basic Life Support (BLS) Provider certifications from 2021 and 2022 πŸ₯πŸ†˜. Beyond medical training, she achieved Cambridge English Advanced (C1) – Grade A in 2019 πŸ“–πŸ‡¬πŸ‡§. These certifications reflect her commitment to excellence in both emergency care and multilingual communication in the medical field. πŸš€

Research Focus

Ms. Annik Caliezi’s research primarily focuses on dermatology 🩺, with a specific emphasis on hidradenitis suppurativa (HS) πŸ”¬, a chronic inflammatory skin disease. Her work examines the impact of HS on sexual quality of life ❀️, addressing the psychological, emotional, and physical challenges faced by patients. Through her studies, she highlights the burden of HS πŸ€•, emphasizing the need for better patient care, awareness, and treatment strategies πŸ“’. Her research contributes to dermatological advancements, aiming to improve both clinical outcomes and overall well-being 😊 for individuals affected by this debilitating condition.

Publication Top Notes